Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Shares Outstanding (2016 - 2025)

Xtant Medical Holdings has reported Shares Outstanding over the past 16 years, most recently at $140.0 million for Q4 2025.

  • Quarterly Shares Outstanding rose 0.71% to $140.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $140.0 million through Dec 2025, up 0.71% year-over-year, with the annual reading at $140.0 million for FY2025, 0.71% up from the prior year.
  • Shares Outstanding was $140.0 million for Q4 2025 at Xtant Medical Holdings, roughly flat from $140.0 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $140.0 million in Q4 2025 and troughed at $86.7 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $119.3 million (2023), against an average of $115.4 million.
  • Year-over-year, Shares Outstanding skyrocketed 555.7% in 2021 and then increased 0.7% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $87.1 million in 2021, then grew by 25.04% to $108.9 million in 2022, then increased by 19.57% to $130.2 million in 2023, then rose by 6.81% to $139.0 million in 2024, then rose by 0.71% to $140.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Shares Outstanding are $140.0 million (Q4 2025), $140.0 million (Q3 2025), and $139.3 million (Q2 2025).